Cargando…

Candesartan—the next anti-amyloid drug?

This scientific commentary refers to ‘Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer's disease’ by Hajjar et al. (https://doi.org/10.1093/braincomms/fcac270).

Detalles Bibliográficos
Autor principal:	Yasar, Sevil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Scientific Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683388/ https://www.ncbi.nlm.nih.gov/pubmed/36440098 http://dx.doi.org/10.1093/braincomms/fcac293

Ejemplares similares

An anti-amyloid therapy works for Alzheimer’s disease: why has it taken so long and what is next?
por: Hardy, John, et al.
Publicado: (2023)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Targeting MCAM for next-generation modulation of leucocyte trafficking
por: Schneider-Hohendorf, Tilman, et al.
Publicado: (2023)

Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?
por: Groot, Colin, et al.
Publicado: (2022)

Preclinical Alzheimer’s disease: how to predict who will decline next year?
por: Hanseeuw, Bernard J, et al.
Publicado: (2023)

Biological single-particle imaging using XFELs – towards the next resolution revolution
por: Oberthür, Dominik
Publicado: (2018)

Eigenvector centrality and its variability over time are promising indicators of alterations in brain function due to early amyloid deposition
por: Skouras, Stavros
Publicado: (2023)

Candesartan in heart failure
por: Ripley, Toni L, et al.
Publicado: (2006)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Neutron crystallography aids in drug design
por: Blakeley, M. P.
Publicado: (2016)

Intracellular drug binding affinities by NMR
por: Madl, Tobias
Publicado: (2021)

Effect of Extracellular Matrix Stiffness on Candesartan Efficacy in Anti-Fibrosis and Antioxidation
por: Zhu, Tong, et al.
Publicado: (2023)

Multiple chemical scaffolds inhibit a promising Leishmania drug target
por: Walkinshaw, Malcolm
Publicado: (2014)

Plasticity enhancement in pharmaceutical drugs by water of crystallization: unusual slip planes
por: Reddy, C. Malla
Publicado: (2019)

Applying Different Techniques to Improve the Bioavailability of Candesartan Cilexetil Antihypertensive Drug
por: Aly, Usama Farghaly, et al.
Publicado: (2020)

Candesartan Restores the Amyloid Beta-Inhibited Proliferation of Neural Stem Cells by Activating the Phosphatidylinositol 3-Kinase Pathway
por: Choi, Hojin, et al.
Publicado: (2017)

Preferred antiretroviral drugs for the next decade of scale up
por: Andrieux-Meyer, Isabelle, et al.
Publicado: (2012)

Candesartan cilexetil in the treatment of chronic heart failure
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

Cardio classics revisited – focus on the role of candesartan
por: De Rosa, Maria Leonarda
Publicado: (2010)

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation (†)
por: Vaculikova, Eliska, et al.
Publicado: (2012)

Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats
por: Uhm, Jae-Sun, et al.
Publicado: (2014)

Candesartan could ameliorate the COVID-19 cytokine storm
por: Elkahloun, Abdel G., et al.
Publicado: (2020)

Candesartan cilexetil: COVID-19 pneumonia: case report
Publicado: (2020)

Repurposing Candesartan Cilexetil as Antibacterial Agent for MRSA Infection
por: Xu, Lanlan, et al.
Publicado: (2021)

Population Pharmacokinetics of Candesartan in Patients with Chronic Heart Failure
por: Kassem, Imad, et al.
Publicado: (2020)

Next-generation Internet
por: Engebretson, J
Publicado: (2002)

What will they think of next?
por: Haas, Laura
Publicado: (2003)

Building the next IT revolution
por: Lloyd, Steve
Publicado: (2003)

Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)
por: Bönner, Gerd, et al.
Publicado: (2011)

The Grid - the next generation internet
por: Gimblett, A
Publicado: (2003)

Modeling amyloids in bacteria
por: Villar-Piqué, Anna, et al.
Publicado: (2012)

The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia
por: Quinlan, Sean, et al.
Publicado: (2019)

Do amyloid fibrils induce inflammation, or does inflammation generate amyloid fibrils?
por: Rothbard, Jonathan B.
Publicado: (2022)

Evaluation of Ameliorative Effect of Quercetin and Candesartan in Doxorubicin-Induced Cardiotoxicity
por: Majhi, Sagarika, et al.
Publicado: (2022)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Candesartan prevents impairment of recall caused by repeated stress in rats
por: Braszko, Jan Józef, et al.
Publicado: (2012)

Design and development and evaluation of candesartan cilexetil liquid filling formulations
por: Deepthi, Y., et al.
Publicado: (2015)

Erratum to: Effects of adriamycin and candesartan on the collagen and elastin of the aorta in rats
por: Uhm, Jae-Sun, et al.
Publicado: (2015)

Development of Orodispersible Tablets of Candesartan Cilexetil-β-cyclodextrin Complex
por: Sravya, Maddukuri, et al.
Publicado: (2013)

Therapeutic of Candesartan and Music Therapy in Diabetic Retinopathy with Depression in Rats
por: Luo, Chengping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vgqu4hhn2mjq78ivj1e693ehs3